BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 18190442)

  • 21. CD56+ blastic transformation of chronic myeloid leukemia involving the skin.
    Kaddu S; Beham-Schmid C; Zenahlik P; Kerl H; Cerroni L
    J Cutan Pathol; 1999 Nov; 26(10):497-503. PubMed ID: 10599940
    [TBL] [Abstract][Full Text] [Related]  

  • 22. State of the art in myeloid sarcoma.
    Klco JM; Welch JS; Nguyen TT; Hurley MY; Kreisel FH; Hassan A; Lind AC; Frater JL
    Int J Lab Hematol; 2011 Dec; 33(6):555-65. PubMed ID: 21883967
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinicopathologic and immunophenotypic analysis of myeloid sarcoma].
    Li JM; Liu WP; Zhang MH; Wei X; Gu JM; Han AJ; Wu WQ; Chen XY
    Zhonghua Bing Li Xue Za Zhi; 2006 Oct; 35(10):606-11. PubMed ID: 17134569
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utility of myeloperoxidase stain in the differential diagnosis of leukemia cutis vs. hystiocitoid Sweet syndrome.
    Valerón-Almazán P; Bastida J; Vilar J; Santana N; Medina C; Carretero G
    Dermatol Online J; 2011 Apr; 17(4):11. PubMed ID: 21549086
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Morphological and immunohistochemical characteristics of blastic NK-cell lymphoma].
    Leenman EE; Krivolapov IuA
    Arkh Patol; 2005; 67(5):35-7. PubMed ID: 16323479
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of CD163 in dermatofibroma, cellular fibrous histiocytoma, and dermatofibrosarcoma protuberans: comparison with CD68, CD34, and Factor XIIIa.
    Sachdev R; Sundram U
    J Cutan Pathol; 2006 May; 33(5):353-60. PubMed ID: 16640542
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Leukemia cutis in association with cutaneous epidermal malignancies.
    Ra S; Su A; Ellison D; Koperski J; Bonilla M; Robbins B
    J Cutan Pathol; 2012 Oct; 39(10):971-6. PubMed ID: 22845783
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative analysis of detecting monocytic cells and their aberrancy.
    Dunphy CH
    Appl Immunohistochem Mol Morphol; 2011 Jul; 19(4):336-40. PubMed ID: 21293259
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunohistochemistry is a more sensitive marker for the detection of myeloperoxidase in acute myeloid leukemia compared with flow cytometry and cytochemistry.
    Saravanan L; Juneja S
    Int J Lab Hematol; 2010 Feb; 32(1 Pt 1):e132-6. PubMed ID: 19077157
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Extramedullary myeloid cell tumors arising in the setting of chronic myelomonocytic leukemia. A report of two cases.
    Elenitoba-Johnson K; Hodges GF; King TC; Wu CD; Medeiros LJ
    Arch Pathol Lab Med; 1996 Jan; 120(1):62-7. PubMed ID: 8554447
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Morphological diagnosis of myeloid sarcomas].
    Leenman EE; Krivolapov IuA
    Arkh Patol; 2009; 71(6):24-8. PubMed ID: 20131502
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cytochemical markers of differentiation in acute leukemia.
    Catovsky D; de Salvo Cardullo L; O'Brien M; Morilla R; Costello C; Galton D; Ganeshaguru K; Hoffbrand V
    Cancer Res; 1981 Nov; 41(11 Pt 2):4824-32. PubMed ID: 6271396
    [No Abstract]   [Full Text] [Related]  

  • 33. Cutaneous presentation of aleukemic monoblastic leukemia cutis - a case report and review of literature with focus on immunohistochemistry.
    Hejmadi RK; Thompson D; Shah F; Naresh KN
    J Cutan Pathol; 2008 Oct; 35 Suppl 1():46-9. PubMed ID: 18544052
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a small subpopulation of candidate leukemia-initiating cells in the side population of patients with acute myeloid leukemia.
    Moshaver B; van Rhenen A; Kelder A; van der Pol M; Terwijn M; Bachas C; Westra AH; Ossenkoppele GJ; Zweegman S; Schuurhuis GJ
    Stem Cells; 2008 Dec; 26(12):3059-67. PubMed ID: 19096043
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bone marrow trephine morphology and immunohistochemical findings in chronic myelomonocytic leukaemia.
    Ngo NT; Lampert IA; Naresh KN
    Br J Haematol; 2008 Jun; 141(6):771-81. PubMed ID: 18371110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. De novo myeloid sarcoma in a 4-month-old infant: a case report and review of the literature.
    Bain EE; Rothman I; Lin L
    J Cutan Pathol; 2013 Mar; 40(3):321-5. PubMed ID: 23095217
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CD30 Expression Is Rare in Myeloid Leukemia Cutis: A Study of 55 Cases and Implications for Routine Diagnostic Algorithms.
    Ogunrinade O; Terrano D; Chiu A; Pulitzer M
    Am J Dermatopathol; 2017 May; 39(5):351-357. PubMed ID: 27893466
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TdT expression in Merkel cell carcinoma: potential diagnostic pitfall with blastic hematological malignancies and expanded immunohistochemical analysis.
    Sur M; AlArdati H; Ross C; Alowami S
    Mod Pathol; 2007 Nov; 20(11):1113-20. PubMed ID: 17885674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunophenotypic profile of acute leukemia: critical analysis and insights gained at a tertiary care center in India.
    Gujral S; Badrinath Y; Kumar A; Subramanian PG; Raje G; Jain H; Pais A; Amre Kadam PS; Banavali SD; Arora B; Kumar P; Hari Menon VG; Kurkure PA; Parikh PM; Mahadik S; Chogule AB; Shinde SC; Nair CN
    Cytometry B Clin Cytom; 2009 May; 76(3):199-205. PubMed ID: 18803279
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leukemia cutis (involving chronic lymphocytic leukemia) within excisional specimens: a series of 6 cases.
    Walther BS; Gibbons G; Chan EF; Ziselman E; Rothfleisch JE; Willard RJ; Baldassano MF
    Am J Dermatopathol; 2009 Apr; 31(2):162-5. PubMed ID: 19318802
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.